Prognostic factors: Rationale and methods of analysis and integration

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Breast Cancer Research and Treatment

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1007/BF00666211PMID 7819579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A practical application of neural network analysis for predicting outcome of individual breast cancer patients

  2005cited by this paper
• A demonstration that breast cancer recurrence can be predicted by Neural Network analysis

  2005cited by this paper
• Proportional hazards and recursive partitioning and amalgamation analyses of the southwest oncology group node-positive adjuvant CMFVP breast cancer data base: a pilot study

  2005cited by this paper
• Why do so many prognostic factors fail to pan out?

  2005cited by this paper
• A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancer

  2005cited by this paper
• Survival analysis of censored data: Neural network analysis detection of complex interactions between variables

  2004cited by this paper
• Do we really need prognostic factors for breast cancer?

  2004cited by this paper
• The Statistical Analysis of Failure Time Data

  2003cited by this paper
• How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer

  1993cited by this paper
• Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial.

  1993cited by this paper
• Relative risk trees for censored survival data.

  1992cited by this paper
• Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations.

  1991cited by this paper
• A comparison of estimated proportional hazards models and regression trees.

  1989cited by this paper
• Regression and recursive partition strategies in the analysis of medical survival data.

  1988cited by this paper
• Regression Trees for Censored Data

  1988cited by this paper
• Tree-structured survival analysis.

  1985cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Making a rating scale that measures.

  1933cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Tratamiento del cáncer de mama infiltrante localizado: nuevos desafíos

  2021cites this paper
• Prise en charge des cancers du sein infiltrants localisés : les nouveaux enjeux

  2021cites this paper
• Comment on " Being rational over blood ratios in veterinary hematology".

  2021cites this paper
• p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.

  2020cites this paper
• Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer

  2016cites this paper
• Quantitative electrochemical detection of cathepsin B activity in breast cancer cell lysates using carbon nanofiber nanoelectrode arrays toward identification of cancer formation.

  2015cites this paper
• Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model

  2015cites this paper
• Use of predictive biomarkers in phase 2 trials.

  2015cites this paper
• Artificial Neural Network Analysis in Preclinical Breast Cancer

  2013cites this paper
• Prise en charge thérapeutique des cancers du sein infiltrants localisés

  2013cites this paper
• The Nottingham Prognostic Index for Invasive Carcinoma of the Breast

  2008cites this paper
• Comparing the predictive value of neural network models to logistic regression models on the risk of death for small-cell lung cancer patients.

  2006cites this paper
• Twenty‐five years of follow‐up in patients with operable breast carcinoma

  2006cites this paper
• in breast cancer

  2004cites this paper
• The relationship between prognostic and predictive factors in the management of breast cancer

  2004cites this paper
• The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer

  2003cites this paper
• The Role of Prognostic Factors in Cancer Research

  2003cites this paper
• Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.

  2002cites this paper
• Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer.

  2002cites this paper
• The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer

  2002cites this paper
• Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis

  2002cites this paper
• Deaths from breast cancer: tackling multidimensionality and non-linearity by correspondence analysis.

  2000cites this paper
• On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology.

  2000cites this paper
• Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2

  1999cites this paper
• Artificial Neural Networks Applied to Survival Prediction in Breast Cancer

  1999cites this paper
• Reasoning with uncertainty in pathology: artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer patients.

  1999cites this paper
• Validity of neural network in sleep apnea.

  1999cites this paper
• Artificial intelligence for clinicians

  1999cites this paper
• A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients.

  1999cites this paper
• Prognostic factors: guidelines for investigation design and state of the art analytical methods.

  1998cites this paper
• Analysis of image cytometry data of fine needle aspirated cells of breast cancer patients: a comparison between logistic regression and artificial neural networks.

  1998cites this paper
• Cell proliferation in 3,800 node‐negative breast cancers: Concistency over time of biological and clinical information provided by 3H‐Thymidine labelling index

  1997cites this paper
• Prediction of nodal metastasis and prognosis in breast cancer: a neural model.

  1997cites this paper
• Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions.

  1997cites this paper
• The detection of nodal metastasis in breast cancer using neural network techniques

  1996cites this paper
• Prognostic variables and future predictors of behaviour and response.

  1996cites this paper
• p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.

  1996cites this paper
• Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers.

  1996cites this paper
• A predictive index of axillary nodal involvement in operable breast cancer.

  1996cites this paper
• Prognostic factors for patients with carcinoma of the breast.

  1995cites this paper